Integral Health Asset Management, LLC Moon Lake Immunotherapeutics Transaction History
Integral Health Asset Management, LLC
- $859 Million
- Q1 2025
A detailed history of Integral Health Asset Management, LLC transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 200,000 shares of MLTX stock, worth $11 Million. This represents 0.91% of its overall portfolio holdings.
Number of Shares
200,000
Previous 200,000
-0.0%
Holding current value
$11 Million
Previous $10.6 Million
26.48%
% of portfolio
0.91%
Previous 0.95%
Shares
4 transactions
Others Institutions Holding MLTX
# of Institutions
160Shares Held
55.2MCall Options Held
481KPut Options Held
229K-
Bvf Inc San Francisco, CA19.8MShares$1.09 Billion33.91% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$468 Million35.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.97MShares$164 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$153 Million1.75% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.48MShares$81.4 Million0.01% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $2.03B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...